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Modern medicine should not dis-
card the advances in blood transfusion.
Day by day, new and more intensive
protocols are being developed in order
to increase survival and cure rates in
patients, especially those affected by
cancer. Moreover, genetic diseases such
as Hemophilia A or B, urban violence
and traffic accidents have increased the
needs related to whole blood and its
components and industrially derived
products.
Obtaining blood supplies of suffi-
cient quality and quantity while preserv-
ing the health of donors is an impor-
tant challenge for the Blood Transfu-
sion Institutions. Increasing invest-
ments have been made in serology con-
trol in order to promote recipient pro-
tection, and this is at present the main
focus of donor screening. The Brazil-
ian rules and laws are very strict in rela-
tion to serological control, and penal-
ties are laid down for professionals and
Institutions that do not carry out the
determinations.
Clinical aspects like those showed
in the paper “Iron Deficiency in Blood
Donors” (São Paulo Med J/Rev Paul
Med 2001;119(4):132-4) are rarely
studied and presented in our country,
in spite of the high frequency of anemia
in our population and the development
of an important public Blood
Transfusion System. Iron deficiency is
very common worldwide, especially in
developing countries. In general,
Brazilian blood donors are poor people,
who have low income and non-
standard life conditions.
Several papers have shown that de-
pletion of iron reserves and iron de-
pendent anemia are more frequent
among blood donors, particularly
among females and multi-time donors.
It is known that multi-time donors are
the safest blood donors. Frequent do-
nation, performing frequent serologi-
cal screening, reduces the probability
of infectious diseases being transmit-
ted by blood.
The major reason for determining
the donor’s hemoglobin concentration
prior to donation is to ensure either
that the donor does not have pre-ex-
isting anemia or that the donor will not
be made anemic by the blood dona-
tion. Iron deficiency may exist in the
absence of overt anemia. Over the past
decade, several studies have attempted
to assess the appropriate minimum
hemoglobin levels by determining the
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ability of proposed cutoffs to detect
donors with iron deficiency in the ab-
sence of overt anemia. Unfortunately,
all the proposed minimum hemoglobin
levels are poorly predictive of body iron
storage.
If the intent is to ensure that do-
nors do not become iron depleted, it
will be necessary to perform a more di-
rect test for measurement of iron me-
tabolism, such as serum ferritin, which
is not readily available due to the com-
plexity and expense of the assay. Addi-
tional attention to quality assurance of
donor screening procedures is war-
ranted due to the situations that exist
in some blood transfusion settings.
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